Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: Role of TSLP

BMC Immunology

Volumn 7, Issue , 2006, Pages

  Jiang, Qi ^a   Su, Hua ^a   Knudsen, Geoffry ^a   Helms, Whitney ^a   Su, Lishan ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; ONTOGENY; PARACRINE SIGNALING; PERINATAL PERIOD; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; THYMUS; TISSUE CULTURE; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD8; CELLS, CULTURED; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; MICE; ORGAN CULTURE TECHNIQUES; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 33646181015     PISSN: 14712172     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-7-6     Document Type: Article

References (59)

1. Mathis D, Benoist C: Back to central tolerance. Immunity 2004, 20(5):509-516.
2. Sprent J, Surh CD: Knowing one's self: central tolerance revisited. Nat Immunol 2003, 4(4):303-304.
3. Sakaguchi S, Takahashi T, Nishizuka Y: Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-I effector cells for oocytes damage after adoptive transfer. J Exp Med 1982, 156(6):1565-1576.
4. Sakaguchi S, Takahashi T, Nishizuka Y: Study on cellular events in postthymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-I cells in normal female mice for the prevention of oophoritis. J Exp Med 1982, 156(6):1577-1586.
5. Sakaguchi S, Sakaguchi N: Thymus and autoimmunity. capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J Exp Med 1990, 172(2):537-545.
6. Smith H, Chen IM, Kubo R, Tung KS: Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus. Science 1989, 245(4919):749-752.
7. Asano M, Toda M, Sakaguchi N, Sakaguchi S: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996, 184(2):387-396.
8. Smith H, Sakamoto Y, Kasai K, Tung KS: Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol 1991, 147(9):2928-2933.
9. Sakaguchi S: Naturally Arising CD4+ Regulatory T Cells for Immunologic Self-Tolerance and Negative Control of Immune Responses. Annu Rev Immunol 2004, 22:531-562.
10. Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2(6):389-400.
11. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 196(12):1875-1886.
12. Apostolou I, von Boehmer H: In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004, 199(10):1401-1408.
13. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27(1):20-21.
14. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27(1):68-73.
15. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299(5609):1057-1061.
16. Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4(4):337-342.
17. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, Haas DW, Unutmaz D: HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells. PLoS Biol 2004, 2(7):E198.
18. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4(4):330-336.
19. Rudensky A: Foxp3 and dominant tolerance. Philos Trans R Soc Lond B Biol Sci 2005, 360(1461):1645-1646.
20. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6(4):345-352.
21. Schwartz RH: Natural regulatory T cells and self-tolerance. Nat Immunol 2005, 6(4):327-330.
22. Hogquist KA, Baldwin TA, Jameson SC: Central tolerance: learning self-control in the thymus. Nat Rev Immunol 2005, 5(10):772-782.
23. Liang S, Alard P, Zhao Y, Parnell S, Clark SL, Kosiewicz MM: Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005, 201(1):127-137.
24. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22(3):329-341.
25. Wan YY, Flavell RA: Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 2005, 102(14):5126-5131.
26. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A. Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002, 3(7):673-680.
27. Gilliet M, Soumellis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R, Liu YJ: Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003, 197(8):1059-1063.
28. Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R, Liu YJ: Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 2004, 5(4):426-434.
29. Al-Shami A, Spolski R, Kelly J, Fry T, Schwartzberg PL, Pandey A, Mackall CL, Leonard WJ: A role for thymic stromall lymphopoietin in CD4(+) T cell development. J Exp Med 2004, 200(2):159-168.
30. Dujardin HC, Burlen-Defranoux O, Boucontet L, Vieira P, Cumano A, Bandeira A: Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells. Proc. Natl Acad Sci USA 2004, 101(40):14473-14478.
31. Fontenot JD, Dooley JL, Farr AG, Rudensky AY: Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005, 202(7):901-906.
32. Tai X, Cowan M, Feigenbaum L, Singer A: CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005, 6(2):152-162.
33. Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, Cao, W, Liu YJ: Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005, 436(7054):1181-1185.
34. Ray RJ, Furlonger C, Williams DE, Paige CJ: Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol 1996, 26(1):10-16.
35. Sims JE, Williams DE, Morrissey PJ, Garka. K, Foxworthe D, Price V, Friend SL, Farr A, Bedell MA, Jenkins NA, Copeland NG, Grabstein K, Paxton RJ: Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 2000, 192(5):671-680.
36. Carpino N, Thierfelder WE, Chang MS, Saris C, Turner SJ, Ziegler SF, He JN: Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Mol Cell Biol 2004, 24(6):2584-2592.
37. Osborn MJ, Ryan PL, Kirchhof N, Panoskaltsis-Mortari A, Mortari F, Tudor KS: Overexpression of murine TSLP impairs lymphopoiesis and myelopoiesis. Blood 2004, 103(3):843-851.
38. Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG, Ziegler SF, Leonard WJ, Lodish HF: Cloning of a receptor subunit required for signaling by thymic stromall lymphopoietin. Nat Immunol 2000, 1(1):59-64.
39. Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, Muller W, Largaespada DA, Copeland NG, Jenkins NA, Farr AG, Ziegler SF, Morrissey PJ, Paxton R, Sims JE: Cloning of the murine thymic stromall lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000, 192(5):659-670.
40. Isaksen DE, Baumann H, Zhou B, Nivollet S, Farr AG, Levin SD, Ziegler SF: Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction. J Immunol 2002, 168(7):3288-3294.
41. Kang J, Der SD: Cytokine functions in the formative stages of a lymphocyte's life. Curr Opin Immunol 2004, 16(2):180-190.
42. Vosshenrich CA, Cumano A, Muller W, Di Santo JP, Vieira P: Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat Immunol 2003, 4(8):773-779.
43. Schramm C, Huber S, Protschka M, Czochra P, Burg J, Schmitt E, Lohse AW, Galle PR, Blessing M: TGF(beta) regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int Immunol 2004, 16(9):1241-1249.
44. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY: A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005, 6(11):1142-1151.
45. Ihle JN: The Stat family in cytokine signaling. Curr Opin Cell Biol 2001, 13(2):211-217.
46. Moriggl R, Sexl V, Piekorz P. Topham D, Ihle JN: Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 1999, 11(2):225-230.
47. Viguier M, Lemaitre F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L: Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004, 173(2):1444-1453.
48. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram, P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004, 10(9):942-949.
49. Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF: Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004, 20(1):107-118.
50. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y: Human immunodeficiency virus-driven expansion of CD4+CD25+ Regulatory T cells Which Suppress HIV-specific CD4 T-cell Responses in HIV-infected Patients. Blood 2004, 104(10):3249-3256.
51. Dittmer U, He H, Messer RJ, Schimmer S, Olbrich AR, Ohlen C, Greenberg PD, Stromnes IM, Iwashiro M, Sakaguchi S, Evans LH, Peterson KE, Yang G, Hasenkrug KJ: Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004, 20(3):293-303.
52. Beilharz: MW, Sammels LM, Paun A, Shaw K, van Eeden P, Watson MW, Ashdown ML: Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. J Immunol 2004, 172(8):4917-4925.
53. Torgerson TR, Ochs HD: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a model of immune dysregulation. Curr Opin Allergy Clin Immunol 2002, 2(6):481-487.
54. Morse SS, Sakaguchi N, Sakaguchi S: Virus and autoimmunitry: induction of autoimmune disease in mice by mouse T lymphotropic virus (MTLV) destroying CD4+ T cells. J Immunol 1999, 162(9):5309-5316.
55. Hornum L, Markholst H: New autoimmune genes and the pathogenesis of type 1 diabetes. Curr Diab Rep 2004, 4(2):135-142.
56. Boyer O, Saadoun D, Abriol J, Dodille M, Piette JC, Cacoub P, Klatzmann D: CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004, 103(9):3428-3430.
57. Coffield VM, Jiang Q, Su L: A genetic approach to inactivating chemokine receptors using a modified viral protein. Nat Biotechnol 2003, 21(11):1321-1327.
58. Kovalev GI, Franklin DS, Coffield VM, Xiong Y, Su L: An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. J Immunol 2001, 167(6):3285-3292.
59. Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor betal production and responsiveness. J Exp Med 2002, 196(2):237-246.